PUMA BIOTECHNOLOGY, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2012
Total Assets: $151.7M
Liabilities Breakdown FY2012
Total Liabilities: $22.8M
Asset Breakdown
Total Assets: $151.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $137.4M | 90.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.5M | 1.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $12.8M | 8.4% |
Liabilities Breakdown
Total Liabilities: $22.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $482.0K | 2.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $22.3M | 97.9% |